6-161048888-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005922.4(MAP3K4):āc.616A>Gā(p.Ile206Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000761 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K4 | NM_005922.4 | c.616A>G | p.Ile206Val | missense_variant | 3/27 | ENST00000392142.9 | NP_005913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K4 | ENST00000392142.9 | c.616A>G | p.Ile206Val | missense_variant | 3/27 | 1 | NM_005922.4 | ENSP00000375986 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152266Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000399 AC: 100AN: 250824Hom.: 0 AF XY: 0.000435 AC XY: 59AN XY: 135552
GnomAD4 exome AF: 0.000796 AC: 1163AN: 1461844Hom.: 0 Cov.: 34 AF XY: 0.000806 AC XY: 586AN XY: 727222
GnomAD4 genome AF: 0.000427 AC: 65AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.616A>G (p.I206V) alteration is located in exon 3 (coding exon 3) of the MAP3K4 gene. This alteration results from a A to G substitution at nucleotide position 616, causing the isoleucine (I) at amino acid position 206 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at